JP Morgan Chase’s HealthEquity HQY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $102M | Sell |
1,158,837
-24,574
| -2% | -$2.08M | 0.01% | 1060 |
|
|
2026
Q1 | $96.4M | Buy |
1,183,411
+18,100
| +2% | +$1.49M | 0.01% | 1007 |
|
|
2025
Q4 | $107M | Sell |
1,165,311
-39,766
| -3% | -$3.81M | 0.01% | 913 |
|
|
2025
Q3 | $114M | Buy |
1,205,077
+124,283
| +11% | +$11.7M | 0.01% | 929 |
|
|
2025
Q2 | $113M | Buy |
1,080,794
+176,435
| +20% | +$16.7M | 0.01% | 888 |
|
|
2025
Q1 | $79.9M | Sell |
904,359
-167,907
| -16% | -$17.2M | 0.01% | 1052 |
|
|
2024
Q4 | $103M | Sell |
1,072,266
-143,055
| -12% | -$13.3M | 0.01% | 920 |
|
|
2024
Q3 | $99.5M | Sell |
1,215,321
-252,244
| -17% | -$19.5M | 0.01% | 956 |
|
|
2024
Q2 | $127M | Sell |
1,467,565
-68,893
| -4% | -$5.57M | 0.01% | 815 |
|
|
2024
Q1 | $125M | Sell |
1,536,458
-555,490
| -27% | -$43.4M | 0.01% | 838 |
|
|
2023
Q4 | $139M | Sell |
2,091,948
-239,157
| -10% | -$16.6M | 0.01% | 750 |
|
|
2023
Q3 | $170M | Sell |
2,331,105
-182,914
| -7% | -$12.4M | 0.02% | 601 |
|
|
2023
Q2 | $159M | Buy |
2,514,019
+39,589
| +2% | +$2.3M | 0.02% | 632 |
|
|
2023
Q1 | $145M | Buy |
2,474,430
+331,735
| +15% | +$20.1M | 0.02% | 653 |
|
|
2022
Q4 | $132M | Sell |
2,142,695
-8,515
| -0.4% | -$572K | 0.02% | 662 |
|
|
2022
Q3 | $144M | Sell |
2,151,210
-305,801
| -12% | -$19.4M | 0.02% | 590 |
|
|
2022
Q2 | $151M | Sell |
2,457,011
-212,694
| -8% | -$13.6M | 0.02% | 600 |
|
|
2022
Q1 | $180M | Buy |
2,669,705
+81,859
| +3% | +$4.42M | 0.02% | 596 |
|
|
2021
Q4 | $114M | Buy |
2,587,846
+589,509
| +29% | +$34.3M | 0.01% | 825 |
|
|
2021
Q3 | $129M | Buy |
1,998,337
+27,078
| +1% | +$1.88M | 0.02% | 747 |
|
|
2021
Q2 | $159M | Sell |
1,971,259
-44,744
| -2% | -$3.41M | 0.02% | 685 |
|
|
2021
Q1 | $137M | Sell |
2,016,003
-64,011
| -3% | -$5.03M | 0.02% | 712 |
|
|
2020
Q4 | $145M | Buy |
2,080,014
+169,805
| +9% | +$10.6M | 0.02% | 637 |
|
|
2020
Q3 | $94.5M | Buy |
1,910,209
+580,416
| +44% | +$31.9M | 0.02% | 718 |
|
|
2020
Q2 | $78M | Buy |
1,329,793
+76,331
| +6% | +$4.22M | 0.02% | 732 |
|
|
2020
Q1 | $63.4M | Buy |
1,253,462
+210,068
| +20% | +$13.9M | 0.01% | 719 |
|
|
2019
Q4 | $77.3M | Buy |
1,043,394
+31,254
| +3% | +$1.95M | 0.01% | 767 |
|
|
2019
Q3 | $57.8M | Buy |
1,012,140
+106,966
| +12% | +$7.1M | 0.01% | 878 |
|
|
2019
Q2 | $59.1M | Buy |
905,174
+90,605
| +11% | +$6.31M | 0.01% | 886 |
|
|
2019
Q1 | $60.3M | Sell |
814,569
-55,785
| -6% | -$3.92M | 0.01% | 874 |
|
|
2018
Q4 | $51.9M | Sell |
870,354
-135,317
| -13% | -$10.9M | 0.01% | 879 |
|
|
2018
Q3 | $94.9M | Sell |
1,005,671
-65,874
| -6% | -$5.67M | 0.02% | 716 |
|
|
2018
Q2 | $80.5M | Sell |
1,071,545
-157,566
| -13% | -$11.3M | 0.02% | 732 |
|
|
2018
Q1 | $74.4M | Buy |
1,229,111
+78,021
| +7% | +$4.22M | 0.02% | 754 |
|
|
2017
Q4 | $53.7M | Buy |
1,151,090
+158,271
| +16% | +$7.84M | 0.01% | 947 |
|
|
2017
Q3 | $49.4M | Buy |
992,819
+31,147
| +3% | +$1.45M | 0.01% | 936 |
|
|
2017
Q2 | $47.9M | Buy |
961,672
+87,609
| +10% | +$4.1M | 0.01% | 927 |
|
|
2017
Q1 | $37.1M | Sell |
874,063
-93,181
| -10% | -$4.12M | 0.01% | 1087 |
|
|
2016
Q4 | $39.2M | Buy |
967,244
+291,695
| +43% | +$11.3M | 0.01% | 1044 |
|
|
2016
Q3 | $25.6M | Buy |
675,549
+182,935
| +37% | +$5.8M | 0.01% | 1220 |
|
|
2016
Q2 | $15M | Buy |
492,614
+2,400
| +0.5% | +$63K | ﹤0.01% | 1592 |
|
|
2016
Q1 | $12.1M | Buy |
490,214
+70,607
| +17% | +$1.51M | ﹤0.01% | 1665 |
|
|
2015
Q4 | $10.5M | Buy |
419,607
+71,932
| +21% | +$2.21M | ﹤0.01% | 1786 |
|
|
2015
Q3 | $10.3M | Buy |
347,675
+10,900
| +3% | +$343K | ﹤0.01% | 1744 |
|
|
2015
Q2 | $10.8M | Hold |
336,775
| – | – | ﹤0.01% | 1880 |
|
|
2015
Q1 | $8.41M | Buy |
336,775
+12,054
| +4% | +$261K | ﹤0.01% | 2014 |
|
|
2014
Q4 | $8.26M | Buy |
324,721
+11,096
| +4% | +$241K | ﹤0.01% | 2074 |
|
|
2014
Q3 | $5.74M | Buy |
+313,625
| New | +$6.02M | ﹤0.01% | 2276 |
|
Other funds holding HQY
WA
JP Morgan Chase's HQY Position: Q2 2026 in Review
JP Morgan Chase reduced its HealthEquity (HQY) stake by 2.1% in Q2 2026, selling an estimated $2.08M and leaving 1,158,837 shares worth $102M. The position accounts for 0.01% of the portfolio, ranked #1060.
JP Morgan Chase first reported a position in HQY in Q3 2014 and has held it in 48 quarters since. The position peaked at $180M in Q1 2022. 498 funds tracked by Wall St. Rank hold HQY as of Q2 2026.
- JP Morgan Chase held 1,158,837 shares of HealthEquity worth $102M as of Q2 2026.
- JP Morgan Chase sold 24,574 HealthEquity shares in Q2 2026, an estimated $2.08M.
- HealthEquity made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1060 holding.
- JP Morgan Chase first reported a position in HealthEquity in Q3 2014 and has held it in 48 quarters since.
- JP Morgan Chase's HealthEquity position peaked at $180M in Q1 2022.
- 498 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.